

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.84742850 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.84742850 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.60667782 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.60667782 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.22203117 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05572350 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.69261317 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.69261317 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.69261317 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63155246 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.57882749 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.44601005 |
| 13 | urea cycle (GO:0000050) | 5.39973374 |
| 14 | urea metabolic process (GO:0019627) | 5.39973374 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.39877347 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.29754355 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.25605963 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21475535 |
| 19 | protein carboxylation (GO:0018214) | 5.19508508 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.19508508 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.17839101 |
| 22 | cysteine metabolic process (GO:0006534) | 5.15250257 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.13488741 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04643078 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.02057859 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.95212420 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.85304698 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.83673094 |
| 29 | regulation of complement activation (GO:0030449) | 4.72807143 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.70985024 |
| 31 | bile acid metabolic process (GO:0008206) | 4.65882319 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.61157417 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.58401528 |
| 34 | lysine metabolic process (GO:0006553) | 4.58201494 |
| 35 | lysine catabolic process (GO:0006554) | 4.58201494 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.52601222 |
| 37 | phospholipid efflux (GO:0033700) | 4.50157707 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49740337 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.49740337 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.49740337 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.49691888 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.44357434 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 4.43044518 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.38953088 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.38953088 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.37977096 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.36974870 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.36974870 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.27649007 |
| 50 | ethanol oxidation (GO:0006069) | 4.07665242 |
| 51 | cholesterol efflux (GO:0033344) | 4.04660776 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 4.03105087 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.02417772 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.02160833 |
| 55 | glycine metabolic process (GO:0006544) | 4.00410692 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 3.97723132 |
| 57 | coenzyme catabolic process (GO:0009109) | 3.97368789 |
| 58 | cellular glucuronidation (GO:0052695) | 3.95692553 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.94746505 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.91785122 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 3.89067357 |
| 62 | amine catabolic process (GO:0009310) | 3.89067357 |
| 63 | NADH metabolic process (GO:0006734) | 3.87855393 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.85970326 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.85236828 |
| 66 | positive regulation of lipid catabolic process (GO:0050996) | 3.82714436 |
| 67 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82202425 |
| 68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82202425 |
| 69 | glutamate metabolic process (GO:0006536) | 3.82085183 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.81540218 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.79935180 |
| 72 | arginine metabolic process (GO:0006525) | 3.74888916 |
| 73 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73529584 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.73024807 |
| 75 | drug catabolic process (GO:0042737) | 3.70979616 |
| 76 | fibrinolysis (GO:0042730) | 3.68758768 |
| 77 | protein-lipid complex assembly (GO:0065005) | 3.65141169 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65102005 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64781369 |
| 80 | cholesterol homeostasis (GO:0042632) | 3.63430133 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.62191284 |
| 82 | complement activation (GO:0006956) | 3.60746101 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.60453874 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.59366513 |
| 85 | complement activation, classical pathway (GO:0006958) | 3.59274559 |
| 86 | sterol homeostasis (GO:0055092) | 3.58280224 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.57615206 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.56590258 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56581575 |
| 90 | protein activation cascade (GO:0072376) | 3.55148048 |
| 91 | organic acid catabolic process (GO:0016054) | 3.52784773 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.52784773 |
| 93 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.51258232 |
| 94 | cofactor catabolic process (GO:0051187) | 3.50639974 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.50304435 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.49965979 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.49965979 |
| 98 | cell migration involved in heart development (GO:0060973) | 3.49456512 |
| 99 | triglyceride catabolic process (GO:0019433) | 3.48798747 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.46550749 |
| 101 | acute-phase response (GO:0006953) | 3.44351779 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.43285239 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.43285239 |
| 104 | fatty acid oxidation (GO:0019395) | 3.42148966 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.25832944 |
| 106 | neutral lipid catabolic process (GO:0046461) | 3.24594052 |
| 107 | acylglycerol catabolic process (GO:0046464) | 3.24594052 |
| 108 | kidney mesenchyme development (GO:0072074) | 3.19980676 |
| 109 | cardiac myofibril assembly (GO:0055003) | 3.18145891 |
| 110 | regulation of sequestering of triglyceride (GO:0010889) | 3.10702525 |
| 111 | metanephric mesenchyme development (GO:0072075) | 3.07774746 |
| 112 | basement membrane organization (GO:0071711) | 3.06454747 |
| 113 | low-density lipoprotein particle clearance (GO:0034383) | 3.05449999 |
| 114 | fatty acid homeostasis (GO:0055089) | 3.01961007 |
| 115 | oxaloacetate metabolic process (GO:0006107) | 2.94783470 |
| 116 | muscle filament sliding (GO:0030049) | 2.88148487 |
| 117 | actin-myosin filament sliding (GO:0033275) | 2.88148487 |
| 118 | cGMP-mediated signaling (GO:0019934) | 2.78940695 |
| 119 | heart trabecula formation (GO:0060347) | 2.77942229 |
| 120 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.75329096 |
| 121 | myofibril assembly (GO:0030239) | 2.72181444 |
| 122 | creatine metabolic process (GO:0006600) | 2.62031970 |
| 123 | gluconeogenesis (GO:0006094) | 2.58422276 |
| 124 | actin-mediated cell contraction (GO:0070252) | 2.57463437 |
| 125 | protein heterotrimerization (GO:0070208) | 2.56599776 |
| 126 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.56515689 |
| 127 | paraxial mesoderm development (GO:0048339) | 2.55749942 |
| 128 | extracellular fibril organization (GO:0043206) | 2.46744970 |
| 129 | 4-hydroxyproline metabolic process (GO:0019471) | 2.44294023 |
| 130 | barbed-end actin filament capping (GO:0051016) | 2.43923537 |
| 131 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.41680682 |
| 132 | muscle cell migration (GO:0014812) | 2.40651028 |
| 133 | atrioventricular valve morphogenesis (GO:0003181) | 2.35845067 |
| 134 | biotin metabolic process (GO:0006768) | 2.35098592 |
| 135 | hexose biosynthetic process (GO:0019319) | 2.33790931 |
| 136 | tricarboxylic acid cycle (GO:0006099) | 2.31823425 |
| 137 | adherens junction assembly (GO:0034333) | 2.29652248 |
| 138 | focal adhesion assembly (GO:0048041) | 2.28668284 |
| 139 | cell-substrate adherens junction assembly (GO:0007045) | 2.28668284 |
| 140 | ethanol metabolic process (GO:0006067) | 2.28635122 |
| 141 | myelination in peripheral nervous system (GO:0022011) | 2.28033955 |
| 142 | peripheral nervous system axon ensheathment (GO:0032292) | 2.28033955 |
| 143 | sarcomere organization (GO:0045214) | 2.27601431 |
| 144 | cochlea morphogenesis (GO:0090103) | 2.27019204 |
| 145 | tricarboxylic acid metabolic process (GO:0072350) | 2.26411654 |
| 146 | endothelial cell morphogenesis (GO:0001886) | 2.26054530 |
| 147 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.24453704 |
| 148 | negative regulation of cartilage development (GO:0061037) | 2.22798907 |
| 149 | glycerolipid catabolic process (GO:0046503) | 2.21318529 |
| 150 | aorta morphogenesis (GO:0035909) | 2.21066309 |
| 151 | diacylglycerol metabolic process (GO:0046339) | 2.20994286 |
| 152 | glomerular filtration (GO:0003094) | 2.19719675 |
| 153 | lymph vessel development (GO:0001945) | 2.19022683 |
| 154 | Notch signaling involved in heart development (GO:0061314) | 2.19013643 |
| 155 | endocardial cushion morphogenesis (GO:0003203) | 2.18538605 |
| 156 | regulation of plasminogen activation (GO:0010755) | 2.17871597 |
| 157 | cell proliferation involved in metanephros development (GO:0072203) | 2.16505646 |
| 158 | outer ear morphogenesis (GO:0042473) | 2.15040584 |
| 159 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.14227489 |
| 160 | carnitine shuttle (GO:0006853) | 2.12707238 |
| 161 | response to mercury ion (GO:0046689) | 2.12445890 |
| 162 | trabecula formation (GO:0060343) | 2.11162796 |
| 163 | proline biosynthetic process (GO:0006561) | 2.10450070 |
| 164 | renal filtration (GO:0097205) | 2.10128558 |
| 165 | response to muscle activity (GO:0014850) | 2.07698204 |
| 166 | tooth mineralization (GO:0034505) | 2.07491973 |
| 167 | fatty acid catabolic process (GO:0009062) | 2.07348876 |
| 168 | cardiac muscle contraction (GO:0060048) | 2.07144052 |
| 169 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.06676759 |
| 170 | monosaccharide biosynthetic process (GO:0046364) | 2.06224045 |
| 171 | notochord development (GO:0030903) | 2.06172137 |
| 172 | fatty acid beta-oxidation (GO:0006635) | 2.04908843 |
| 173 | protein retention in ER lumen (GO:0006621) | 2.04752583 |
| 174 | 2-oxoglutarate metabolic process (GO:0006103) | 2.04578602 |
| 175 | negative regulation of catenin import into nucleus (GO:0035414) | 2.04459735 |
| 176 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.04078538 |
| 177 | glomerular basement membrane development (GO:0032836) | 2.03768435 |
| 178 | cell communication by electrical coupling (GO:0010644) | 2.03432686 |
| 179 | proline metabolic process (GO:0006560) | 2.02472054 |
| 180 | lipid particle organization (GO:0034389) | 2.00944070 |
| 181 | fatty acid transmembrane transport (GO:1902001) | 1.99765716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.72319184 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.75829697 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.30683209 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99235199 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.48278269 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.78650000 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65707695 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.20745194 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78604330 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59920361 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38171754 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8096244 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98708421 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93645000 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89914104 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89914104 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89742903 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88001669 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87950180 |
| 20 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.87761823 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86741217 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81671437 |
| 23 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.79307803 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79182484 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75372111 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72448661 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.68667646 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67168384 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.67014834 |
| 30 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.67014834 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66768963 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65975206 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64820062 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64318604 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57838647 |
| 36 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.54886858 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53727466 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51879132 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51478437 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48465264 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.48302771 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.42932453 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42764534 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42763806 |
| 45 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40543400 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39028450 |
| 47 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38899919 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37835882 |
| 49 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34725472 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34578845 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30873949 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30125420 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29666219 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28197445 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25392376 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25319750 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25186208 |
| 58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24505542 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23846007 |
| 60 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.23239796 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21746533 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19119042 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18037550 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17232521 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15039267 |
| 66 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11189820 |
| 67 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11161010 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10835103 |
| 69 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08603821 |
| 70 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08413527 |
| 71 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06348709 |
| 72 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.04892807 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04424778 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01963394 |
| 75 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01656654 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01589075 |
| 77 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01324373 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00959539 |
| 79 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00268716 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00259126 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99874029 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99659858 |
| 83 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99446511 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99269083 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99154320 |
| 86 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98753329 |
| 87 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97989809 |
| 88 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97779226 |
| 89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97496960 |
| 90 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97485241 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97420432 |
| 92 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.96454889 |
| 93 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96195299 |
| 94 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95834929 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95476125 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95358674 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95212986 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94868848 |
| 99 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94649825 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93615428 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93579151 |
| 102 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.91854729 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91226566 |
| 104 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90762682 |
| 105 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90349409 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90198224 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89925235 |
| 108 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89518989 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88274579 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87516423 |
| 111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.86917132 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84981663 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84707322 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81835882 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81392459 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79109215 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78804973 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.75268893 |
| 119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75062618 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73163711 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72579120 |
| 122 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.72285857 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72231446 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71584519 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71525233 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69625078 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69220074 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69148541 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66999128 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66003233 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65999778 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65359429 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65243777 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64952358 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64877632 |
| 136 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.63857741 |
| 137 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61892451 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61270454 |
| 139 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61261929 |
| 140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60053167 |
| 141 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59805890 |
| 142 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59644338 |
| 143 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59624263 |
| 144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.59602603 |
| 145 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59036150 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58712031 |
| 147 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.58080452 |
| 148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.55727056 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55341875 |
| 150 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54929545 |
| 151 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.54435571 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.54435571 |
| 153 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.54242004 |
| 154 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.54153457 |
| 155 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53872557 |
| 156 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53474995 |
| 157 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.53148625 |
| 158 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52169256 |
| 159 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52049476 |
| 160 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.52017611 |
| 161 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.50365313 |
| 162 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.49541011 |
| 163 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.49168858 |
| 164 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49134568 |
| 165 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.49069280 |
| 166 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.49014620 |
| 167 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48778345 |
| 168 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.48221965 |
| 169 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.47315578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.63509303 |
| 2 | MP0005360_urolithiasis | 7.11914085 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79635201 |
| 4 | MP0005365_abnormal_bile_salt | 5.68918418 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.60609681 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.82773432 |
| 7 | MP0000751_myopathy | 3.76083307 |
| 8 | MP0003252_abnormal_bile_duct | 3.60555199 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.49269939 |
| 10 | MP0009840_abnormal_foam_cell | 3.46038599 |
| 11 | MP0004272_abnormal_basement_membrane | 3.39393447 |
| 12 | MP0005083_abnormal_biliary_tract | 3.13948128 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.60415838 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56138792 |
| 15 | MP0000749_muscle_degeneration | 2.54551916 |
| 16 | * MP0005332_abnormal_amino_acid | 2.47965490 |
| 17 | MP0003195_calcinosis | 2.41300106 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.31847814 |
| 19 | MP0000609_abnormal_liver_physiology | 2.21499512 |
| 20 | MP0003279_aneurysm | 2.18789145 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.09571169 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.07851738 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.01342435 |
| 24 | MP0005275_abnormal_skin_tensile | 2.00014109 |
| 25 | MP0006138_congestive_heart_failure | 1.97909949 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.88190099 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.86567468 |
| 28 | MP0005375_adipose_tissue_phenotype | 1.81597757 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.75272366 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.73808041 |
| 31 | MP0005330_cardiomyopathy | 1.69010605 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.67707186 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.66685271 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.66343397 |
| 35 | MP0001299_abnormal_eye_distance/ | 1.65727079 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.65462378 |
| 37 | MP0003868_abnormal_feces_composition | 1.56601079 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.54710772 |
| 39 | MP0001764_abnormal_homeostasis | 1.52319564 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.51729206 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.50084885 |
| 42 | MP0000747_muscle_weakness | 1.49103418 |
| 43 | MP0004233_abnormal_muscle_weight | 1.47340350 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.46954340 |
| 45 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.46184379 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.43963873 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.43204529 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.39462576 |
| 49 | MP0003186_abnormal_redox_activity | 1.39315479 |
| 50 | MP0001879_abnormal_lymphatic_vessel | 1.35687392 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.35386247 |
| 52 | MP0002972_abnormal_cardiac_muscle | 1.35093229 |
| 53 | MP0005670_abnormal_white_adipose | 1.35005481 |
| 54 | MP0005623_abnormal_meninges_morphology | 1.34270528 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.33981524 |
| 56 | MP0002269_muscular_atrophy | 1.33415762 |
| 57 | MP0009697_abnormal_copulation | 1.32058693 |
| 58 | MP0004215_abnormal_myocardial_fiber | 1.31831242 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.30167865 |
| 60 | MP0001958_emphysema | 1.29538686 |
| 61 | * MP0009643_abnormal_urine_homeostasis | 1.28521890 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.28142453 |
| 63 | MP0005451_abnormal_body_composition | 1.26921751 |
| 64 | MP0009764_decreased_sensitivity_to | 1.26725556 |
| 65 | MP0010630_abnormal_cardiac_muscle | 1.25187367 |
| 66 | MP0005595_abnormal_vascular_smooth | 1.24713922 |
| 67 | MP0000598_abnormal_liver_morphology | 1.22323873 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.20270266 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.19672626 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.19250599 |
| 71 | MP0003941_abnormal_skin_development | 1.19064982 |
| 72 | MP0005369_muscle_phenotype | 1.18647243 |
| 73 | MP0002254_reproductive_system_inflammat | 1.18516901 |
| 74 | MP0002249_abnormal_larynx_morphology | 1.17201284 |
| 75 | MP0000750_abnormal_muscle_regeneration | 1.16159845 |
| 76 | MP0002295_abnormal_pulmonary_circulatio | 1.13636146 |
| 77 | MP0003646_muscle_fatigue | 1.13060701 |
| 78 | MP0009763_increased_sensitivity_to | 1.12230020 |
| 79 | MP0003011_delayed_dark_adaptation | 1.11638132 |
| 80 | MP0008469_abnormal_protein_level | 1.08775627 |
| 81 | MP0000604_amyloidosis | 1.07653562 |
| 82 | MP0005171_absent_coat_pigmentation | 1.07433854 |
| 83 | MP0001544_abnormal_cardiovascular_syste | 1.06731930 |
| 84 | MP0005385_cardiovascular_system_phenoty | 1.06731930 |
| 85 | MP0005647_abnormal_sex_gland | 1.06694227 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.06478327 |
| 87 | MP0003942_abnormal_urinary_system | 1.05941533 |
| 88 | MP0003436_decreased_susceptibility_to | 1.00414167 |
| 89 | MP0004130_abnormal_muscle_cell | 0.98750951 |
| 90 | MP0004858_abnormal_nervous_system | 0.98634854 |
| 91 | MP0008775_abnormal_heart_ventricle | 0.96798063 |
| 92 | MP0003959_abnormal_lean_body | 0.94063279 |
| 93 | MP0009250_abnormal_appendicular_skeleto | 0.94039305 |
| 94 | MP0002127_abnormal_cardiovascular_syste | 0.93697832 |
| 95 | MP0003283_abnormal_digestive_organ | 0.93408040 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.92398130 |
| 97 | MP0002971_abnormal_brown_adipose | 0.91209811 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.90086528 |
| 99 | MP0003724_increased_susceptibility_to | 0.89987648 |
| 100 | MP0003385_abnormal_body_wall | 0.89398010 |
| 101 | MP0005187_abnormal_penis_morphology | 0.89124355 |
| 102 | MP0000462_abnormal_digestive_system | 0.87758370 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.87342353 |
| 104 | MP0000733_abnormal_muscle_development | 0.86796918 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.86109604 |
| 106 | MP0005334_abnormal_fat_pad | 0.84099206 |
| 107 | MP0005165_increased_susceptibility_to | 0.81092720 |
| 108 | MP0002128_abnormal_blood_circulation | 0.81011132 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.79394968 |
| 110 | MP0003091_abnormal_cell_migration | 0.79047227 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.76757929 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.76384183 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.74460917 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.74105962 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.73747896 |
| 116 | MP0000343_altered_response_to | 0.73294605 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.73054484 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.72111979 |
| 119 | MP0005408_hypopigmentation | 0.69829866 |
| 120 | MP0003136_yellow_coat_color | 0.69590264 |
| 121 | MP0004085_abnormal_heartbeat | 0.68641389 |
| 122 | MP0001614_abnormal_blood_vessel | 0.67720491 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.67154747 |
| 124 | MP0000049_abnormal_middle_ear | 0.66385889 |
| 125 | MP0001881_abnormal_mammary_gland | 0.65840587 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.64367586 |
| 127 | MP0001756_abnormal_urination | 0.64290784 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.64267428 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.62935805 |
| 130 | MP0003879_abnormal_hair_cell | 0.62631655 |
| 131 | MP0003690_abnormal_glial_cell | 0.62447545 |
| 132 | MP0000266_abnormal_heart_morphology | 0.62397688 |
| 133 | MP0005452_abnormal_adipose_tissue | 0.61381948 |
| 134 | MP0005448_abnormal_energy_balance | 0.60920320 |
| 135 | MP0009672_abnormal_birth_weight | 0.60858592 |
| 136 | MP0000163_abnormal_cartilage_morphology | 0.60291008 |
| 137 | MP0006082_CNS_inflammation | 0.60272655 |
| 138 | MP0001661_extended_life_span | 0.60161016 |
| 139 | MP0005535_abnormal_body_temperature | 0.59935518 |
| 140 | MP0004947_skin_inflammation | 0.59921483 |
| 141 | MP0003075_altered_response_to | 0.59542447 |
| 142 | MP0002697_abnormal_eye_size | 0.59377875 |
| 143 | MP0009115_abnormal_fat_cell | 0.59049122 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.56924205 |
| 145 | MP0005266_abnormal_metabolism | 0.56024840 |
| 146 | MP0002419_abnormal_innate_immunity | 0.53636042 |
| 147 | MP0001853_heart_inflammation | 0.53367698 |
| 148 | MP0009053_abnormal_anal_canal | 0.52255936 |
| 149 | MP0005084_abnormal_gallbladder_morpholo | 0.52175193 |
| 150 | MP0009785_altered_susceptibility_to | 0.51989983 |
| 151 | MP0005166_decreased_susceptibility_to | 0.50359600 |
| 152 | MP0005025_abnormal_response_to | 0.49798811 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.49573308 |
| 154 | MP0000249_abnormal_blood_vessel | 0.49064503 |
| 155 | MP0008873_increased_physiological_sensi | 0.48844050 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.48335930 |
| 157 | MP0002928_abnormal_bile_duct | 0.47956683 |
| 158 | MP0005023_abnormal_wound_healing | 0.46955667 |
| 159 | MP0002970_abnormal_white_adipose | 0.46873628 |
| 160 | MP0003453_abnormal_keratinocyte_physiol | 0.46253319 |
| 161 | MP0003303_peritoneal_inflammation | 0.46074979 |
| 162 | MP0000639_abnormal_adrenal_gland | 0.45540438 |
| 163 | MP0002060_abnormal_skin_morphology | 0.45242477 |
| 164 | MP0001533_abnormal_skeleton_physiology | 0.44283786 |
| 165 | MP0005395_other_phenotype | 0.43956088 |
| 166 | MP0000685_abnormal_immune_system | 0.43700092 |
| 167 | MP0005167_abnormal_blood-brain_barrier | 0.42553167 |
| 168 | MP0003638_abnormal_response/metabolism_ | 0.42114109 |
| 169 | MP0003329_amyloid_beta_deposits | 0.42013107 |
| 170 | MP0002168_other_aberrant_phenotype | 0.41771849 |
| 171 | MP0001243_abnormal_dermal_layer | 0.40328920 |
| 172 | MP0008438_abnormal_cutaneous_collagen | 0.40154353 |
| 173 | MP0002796_impaired_skin_barrier | 0.39318426 |
| 174 | MP0006035_abnormal_mitochondrial_morpho | 0.38966029 |
| 175 | MP0004147_increased_porphyrin_level | 0.38636855 |
| 176 | MP0008874_decreased_physiological_sensi | 0.37800326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.97855259 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.67478921 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.67131134 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.22443083 |
| 5 | Xanthomatosis (HP:0000991) | 6.05038792 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.98055601 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.74979732 |
| 8 | Complement deficiency (HP:0004431) | 5.39482575 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.32239588 |
| 10 | Joint hemorrhage (HP:0005261) | 4.74963656 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.49658593 |
| 12 | Hyperammonemia (HP:0001987) | 4.45974548 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 4.32898103 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31179798 |
| 15 | Epidermoid cyst (HP:0200040) | 4.28324858 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.18249191 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15923008 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.11363616 |
| 19 | Ketosis (HP:0001946) | 4.09963886 |
| 20 | Premature rupture of membranes (HP:0001788) | 4.08342640 |
| 21 | Hyperglycinemia (HP:0002154) | 4.05091815 |
| 22 | Abnormality of complement system (HP:0005339) | 4.03494911 |
| 23 | Protrusio acetabuli (HP:0003179) | 3.97866206 |
| 24 | Hyperglycinuria (HP:0003108) | 3.90295494 |
| 25 | Fat malabsorption (HP:0002630) | 3.83929210 |
| 26 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78001296 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.78000528 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76814674 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.76814674 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.76424468 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.65305368 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63151673 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62819746 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.61987129 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.50752598 |
| 36 | Exercise-induced myalgia (HP:0003738) | 3.50599237 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44735970 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.40946557 |
| 39 | Muscle fiber inclusion bodies (HP:0100299) | 3.40758543 |
| 40 | Myocardial infarction (HP:0001658) | 3.37579642 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37044461 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36325171 |
| 43 | Nemaline bodies (HP:0003798) | 3.35155806 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.27386265 |
| 45 | Increased connective tissue (HP:0009025) | 3.23199681 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 3.23167374 |
| 47 | Spinal rigidity (HP:0003306) | 3.14929201 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.14849673 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04190882 |
| 50 | Muscle fiber splitting (HP:0003555) | 3.01783961 |
| 51 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.96456521 |
| 52 | Ketoacidosis (HP:0001993) | 2.93334614 |
| 53 | Steatorrhea (HP:0002570) | 2.88031045 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.87182023 |
| 55 | Broad metatarsal (HP:0001783) | 2.86222260 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.77840075 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.77649505 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.77277599 |
| 59 | Metabolic acidosis (HP:0001942) | 2.71377544 |
| 60 | Shallow orbits (HP:0000586) | 2.70676903 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.70587326 |
| 62 | Delayed CNS myelination (HP:0002188) | 2.70513876 |
| 63 | Skin nodule (HP:0200036) | 2.69528491 |
| 64 | Glomerulonephritis (HP:0000099) | 2.66867221 |
| 65 | Myoglobinuria (HP:0002913) | 2.66292234 |
| 66 | Spontaneous abortion (HP:0005268) | 2.64171572 |
| 67 | Abnormality of the calf musculature (HP:0001430) | 2.63318087 |
| 68 | * Abnormality of purine metabolism (HP:0004352) | 2.61694832 |
| 69 | Vascular calcification (HP:0004934) | 2.60674298 |
| 70 | Acanthocytosis (HP:0001927) | 2.58109080 |
| 71 | Neck muscle weakness (HP:0000467) | 2.56202856 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55159622 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.55159622 |
| 74 | Aortic aneurysm (HP:0004942) | 2.54424281 |
| 75 | Spastic diplegia (HP:0001264) | 2.52173115 |
| 76 | Cholelithiasis (HP:0001081) | 2.51888368 |
| 77 | Gingival bleeding (HP:0000225) | 2.50112112 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.49409587 |
| 79 | Ventricular tachycardia (HP:0004756) | 2.47907996 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45950464 |
| 81 | Amyloidosis (HP:0011034) | 2.44255883 |
| 82 | Mitral stenosis (HP:0001718) | 2.44223655 |
| 83 | EMG: myopathic abnormalities (HP:0003458) | 2.44071424 |
| 84 | Sudden death (HP:0001699) | 2.43884472 |
| 85 | Esophageal varix (HP:0002040) | 2.43348431 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.42672966 |
| 87 | Gout (HP:0001997) | 2.41448394 |
| 88 | Rhabdomyolysis (HP:0003201) | 2.40610511 |
| 89 | Lipoatrophy (HP:0100578) | 2.40070194 |
| 90 | Exercise-induced muscle cramps (HP:0003710) | 2.36749135 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.35656326 |
| 92 | Menorrhagia (HP:0000132) | 2.35088645 |
| 93 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35004088 |
| 94 | Poikilocytosis (HP:0004447) | 2.34042524 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.30894047 |
| 96 | Lethargy (HP:0001254) | 2.30809523 |
| 97 | Vascular tortuosity (HP:0004948) | 2.29589741 |
| 98 | Malnutrition (HP:0004395) | 2.25575955 |
| 99 | Hydroxyprolinuria (HP:0003080) | 2.21483214 |
| 100 | Abnormality of proline metabolism (HP:0010907) | 2.21483214 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.21308814 |
| 102 | Cholecystitis (HP:0001082) | 2.21297198 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.21297198 |
| 104 | Hypoglycemic seizures (HP:0002173) | 2.21208014 |
| 105 | Back pain (HP:0003418) | 2.21163432 |
| 106 | Aortic dissection (HP:0002647) | 2.19157997 |
| 107 | Pancreatitis (HP:0001733) | 2.18998287 |
| 108 | Round ear (HP:0100830) | 2.18761764 |
| 109 | Hypoplasia of the iris (HP:0007676) | 2.18713980 |
| 110 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17529636 |
| 111 | Soft skin (HP:0000977) | 2.16951163 |
| 112 | Acanthosis nigricans (HP:0000956) | 2.15287844 |
| 113 | Thrombophlebitis (HP:0004418) | 2.15141083 |
| 114 | Arterial tortuosity (HP:0005116) | 2.14357934 |
| 115 | Dilated cardiomyopathy (HP:0001644) | 2.14244159 |
| 116 | Neonatal onset (HP:0003623) | 2.13662960 |
| 117 | Nephritis (HP:0000123) | 2.13452899 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 2.12586971 |
| 119 | Myopathic facies (HP:0002058) | 2.11044329 |
| 120 | Distal lower limb amyotrophy (HP:0008944) | 2.08899987 |
| 121 | Irritability (HP:0000737) | 2.08749919 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 2.08303492 |
| 123 | Turricephaly (HP:0000262) | 2.06824631 |
| 124 | Late onset (HP:0003584) | 2.03669354 |
| 125 | Reticulocytosis (HP:0001923) | 2.03330203 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 2.01893036 |
| 127 | Generalized aminoaciduria (HP:0002909) | 2.01226313 |
| 128 | Vomiting (HP:0002013) | 2.00429236 |
| 129 | Hypertriglyceridemia (HP:0002155) | 2.00299083 |
| 130 | Pulmonary artery stenosis (HP:0004415) | 1.99034675 |
| 131 | Ankle contracture (HP:0006466) | 1.98540063 |
| 132 | Bundle branch block (HP:0011710) | 1.98249679 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.94309361 |
| 134 | Brushfield spots (HP:0001088) | 1.93163531 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.92883080 |
| 136 | Difficulty running (HP:0009046) | 1.92760220 |
| 137 | Abnormal atrioventricular conduction (HP:0005150) | 1.91328155 |
| 138 | Cerebral edema (HP:0002181) | 1.90121783 |
| 139 | Muscle stiffness (HP:0003552) | 1.89882515 |
| 140 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89514502 |
| 141 | Nausea (HP:0002018) | 1.89345808 |
| 142 | Increased serum ferritin (HP:0003281) | 1.88463252 |
| 143 | Oligomenorrhea (HP:0000876) | 1.87657158 |
| 144 | Atrioventricular block (HP:0001678) | 1.87594863 |
| 145 | Increased serum pyruvate (HP:0003542) | 1.84945393 |
| 146 | Limb-girdle muscle atrophy (HP:0003797) | 1.84886901 |
| 147 | Enlarged kidneys (HP:0000105) | 1.84292587 |
| 148 | Limb-girdle muscle weakness (HP:0003325) | 1.83663669 |
| 149 | Ulnar bowing (HP:0003031) | 1.83247856 |
| 150 | Hypoplastic left heart (HP:0004383) | 1.82465537 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.81819165 |
| 152 | Infantile muscular hypotonia (HP:0008947) | 1.81341794 |
| 153 | Polycythemia (HP:0001901) | 1.80819751 |
| 154 | Scapular winging (HP:0003691) | 1.80651322 |
| 155 | Gowers sign (HP:0003391) | 1.80595212 |
| 156 | Rimmed vacuoles (HP:0003805) | 1.80091500 |
| 157 | Slender build (HP:0001533) | 1.79714608 |
| 158 | Coronal craniosynostosis (HP:0004440) | 1.79704003 |
| 159 | Abnormality of glycolysis (HP:0004366) | 1.76656877 |
| 160 | Lymphangioma (HP:0100764) | 1.75014544 |
| 161 | Wormian bones (HP:0002645) | 1.74977879 |
| 162 | Rickets (HP:0002748) | 1.74904347 |
| 163 | Lower limb amyotrophy (HP:0007210) | 1.74457645 |
| 164 | Renal cortical cysts (HP:0000803) | 1.72796651 |
| 165 | Pulmonary embolism (HP:0002204) | 1.72730689 |
| 166 | Abnormality of dentin (HP:0010299) | 1.72652938 |
| 167 | Increased mean platelet volume (HP:0011877) | 1.72632653 |
| 168 | Insulin resistance (HP:0000855) | 1.72143120 |
| 169 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.72136189 |
| 170 | Short nail (HP:0001799) | 1.71143315 |
| 171 | Heart block (HP:0012722) | 1.71050886 |
| 172 | Foot dorsiflexor weakness (HP:0009027) | 1.70512514 |
| 173 | Generalized amyotrophy (HP:0003700) | 1.70279237 |
| 174 | Abnormality of the foot musculature (HP:0001436) | 1.69438299 |
| 175 | Bladder diverticulum (HP:0000015) | 1.68497051 |
| 176 | Calf muscle hypertrophy (HP:0008981) | 1.68279978 |
| 177 | Hypercalcemia (HP:0003072) | 1.67021376 |
| 178 | Difficulty climbing stairs (HP:0003551) | 1.66884308 |
| 179 | Partial duplication of the phalanx of hand (HP:0009999) | 1.65969490 |
| 180 | Myotonia (HP:0002486) | 1.65546110 |
| 181 | * Ectopia lentis (HP:0001083) | 1.65143266 |
| 182 | Bone cyst (HP:0012062) | 1.64746631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.38725616 |
| 2 | ERN1 | 4.88182028 |
| 3 | SIK1 | 4.42941867 |
| 4 | FGFR4 | 3.71211157 |
| 5 | MYLK | 3.30557344 |
| 6 | OBSCN | 2.98258477 |
| 7 | TRIB3 | 2.85906175 |
| 8 | TAOK3 | 2.74895132 |
| 9 | PKN2 | 2.68079049 |
| 10 | LATS2 | 2.50451754 |
| 11 | TYK2 | 2.24580056 |
| 12 | TESK1 | 2.20507628 |
| 13 | MST1R | 2.15816324 |
| 14 | EPHB2 | 2.03620306 |
| 15 | PHKG1 | 2.02854026 |
| 16 | PHKG2 | 2.02854026 |
| 17 | DMPK | 2.00429856 |
| 18 | ERBB4 | 1.95734512 |
| 19 | INSRR | 1.89002204 |
| 20 | PRKD3 | 1.84802368 |
| 21 | FLT3 | 1.80192151 |
| 22 | CAMK1D | 1.76366634 |
| 23 | PTK6 | 1.74605038 |
| 24 | MAPK11 | 1.69064158 |
| 25 | TBK1 | 1.63730146 |
| 26 | NTRK1 | 1.62939009 |
| 27 | LIMK1 | 1.62495057 |
| 28 | NEK9 | 1.58230429 |
| 29 | PAK2 | 1.55460632 |
| 30 | IRAK3 | 1.54796366 |
| 31 | MUSK | 1.51939198 |
| 32 | DDR2 | 1.50072692 |
| 33 | MAP2K3 | 1.48631059 |
| 34 | LATS1 | 1.45792955 |
| 35 | JAK1 | 1.43026023 |
| 36 | MAP3K10 | 1.40652657 |
| 37 | MAP3K14 | 1.32762481 |
| 38 | EPHB1 | 1.30720565 |
| 39 | RIPK1 | 1.30216289 |
| 40 | PIK3CG | 1.29434146 |
| 41 | JAK2 | 1.27648792 |
| 42 | PINK1 | 1.27148738 |
| 43 | DAPK3 | 1.27093539 |
| 44 | ILK | 1.24175401 |
| 45 | PAK6 | 1.22666318 |
| 46 | GRK6 | 1.22383723 |
| 47 | PAK4 | 1.21548648 |
| 48 | TGFBR2 | 1.17085179 |
| 49 | FRK | 1.15854722 |
| 50 | PRKAA2 | 1.14163586 |
| 51 | KDR | 1.14157297 |
| 52 | MAP3K7 | 1.10256041 |
| 53 | MAP2K4 | 1.09769214 |
| 54 | ABL2 | 1.09312082 |
| 55 | CDK6 | 1.07688578 |
| 56 | IKBKE | 1.07626306 |
| 57 | CAMK1G | 1.02812217 |
| 58 | ARAF | 1.02737386 |
| 59 | MAP4K1 | 1.02717664 |
| 60 | MAP3K3 | 1.01690671 |
| 61 | AKT2 | 1.00649229 |
| 62 | DAPK2 | 0.99974268 |
| 63 | LMTK2 | 0.96328359 |
| 64 | CAMK2G | 0.95669685 |
| 65 | CSK | 0.95363221 |
| 66 | MAP3K11 | 0.94485190 |
| 67 | EPHA4 | 0.94143150 |
| 68 | ROCK1 | 0.90170458 |
| 69 | STK38 | 0.89434438 |
| 70 | EPHA2 | 0.88602141 |
| 71 | GRK5 | 0.84761857 |
| 72 | PDK2 | 0.84639142 |
| 73 | MOS | 0.82855532 |
| 74 | FGFR2 | 0.82657799 |
| 75 | ZAP70 | 0.81295132 |
| 76 | CSF1R | 0.80936747 |
| 77 | FGFR3 | 0.80422431 |
| 78 | SMG1 | 0.79539660 |
| 79 | MAPKAPK3 | 0.79084136 |
| 80 | PDGFRB | 0.78083925 |
| 81 | ERBB2 | 0.75983295 |
| 82 | KSR2 | 0.75795375 |
| 83 | CAMK1 | 0.75782153 |
| 84 | ROCK2 | 0.75552008 |
| 85 | KIT | 0.75414901 |
| 86 | MET | 0.72805941 |
| 87 | JAK3 | 0.72325051 |
| 88 | MAPK4 | 0.72218390 |
| 89 | MARK1 | 0.71909659 |
| 90 | CAMK2D | 0.69984670 |
| 91 | CDK12 | 0.69821868 |
| 92 | BLK | 0.69531082 |
| 93 | PRKD1 | 0.69396830 |
| 94 | EPHA3 | 0.69208142 |
| 95 | BMX | 0.69170847 |
| 96 | MAPK12 | 0.66803969 |
| 97 | CAMK2B | 0.66034611 |
| 98 | SGK3 | 0.64357378 |
| 99 | PRKAA1 | 0.64103253 |
| 100 | DYRK1B | 0.63923230 |
| 101 | CDK4 | 0.63400009 |
| 102 | PIM2 | 0.61539392 |
| 103 | PTK2 | 0.60824435 |
| 104 | TTN | 0.59574065 |
| 105 | PRKG2 | 0.59341894 |
| 106 | PAK3 | 0.57862896 |
| 107 | TAOK2 | 0.57770977 |
| 108 | MTOR | 0.56823951 |
| 109 | PRKG1 | 0.56363028 |
| 110 | GSK3A | 0.55329022 |
| 111 | STK10 | 0.53772062 |
| 112 | EEF2K | 0.52465511 |
| 113 | PRKCZ | 0.52014660 |
| 114 | NTRK3 | 0.51810152 |
| 115 | IKBKB | 0.51613918 |
| 116 | PRKACG | 0.51503131 |
| 117 | CHUK | 0.50983477 |
| 118 | TYRO3 | 0.50492055 |
| 119 | CDK8 | 0.50291437 |
| 120 | TIE1 | 0.49884412 |
| 121 | BTK | 0.49785755 |
| 122 | PDPK1 | 0.49310522 |
| 123 | PKN1 | 0.48684546 |
| 124 | NME1 | 0.46925779 |
| 125 | PRKD2 | 0.46907457 |
| 126 | LRRK2 | 0.46663096 |
| 127 | MAP2K6 | 0.46392327 |
| 128 | MAP3K13 | 0.45929446 |
| 129 | BUB1 | 0.45489735 |
| 130 | VRK2 | 0.44528476 |
| 131 | MAP3K5 | 0.43073275 |
| 132 | PIM1 | 0.42129955 |
| 133 | PDGFRA | 0.40996184 |
| 134 | STK4 | 0.40784183 |
| 135 | MAP3K12 | 0.40611514 |
| 136 | EGFR | 0.40526760 |
| 137 | STK3 | 0.40502255 |
| 138 | CAMK2A | 0.40427465 |
| 139 | RPS6KA2 | 0.40382004 |
| 140 | CDK15 | 0.40088611 |
| 141 | STK16 | 0.39258000 |
| 142 | CDK11A | 0.39114911 |
| 143 | MAP2K1 | 0.38698261 |
| 144 | MARK2 | 0.38462682 |
| 145 | IGF1R | 0.38132454 |
| 146 | PAK1 | 0.37906833 |
| 147 | PIK3CA | 0.37704838 |
| 148 | STK38L | 0.35870307 |
| 149 | ICK | 0.35849834 |
| 150 | BRAF | 0.35805466 |
| 151 | IRAK4 | 0.35571119 |
| 152 | TSSK6 | 0.35463347 |
| 153 | MAPK15 | 0.35050899 |
| 154 | ITK | 0.34604643 |
| 155 | MAPK7 | 0.33624486 |
| 156 | HCK | 0.30584725 |
| 157 | RET | 0.30368129 |
| 158 | MAP2K2 | 0.30017189 |
| 159 | ABL1 | 0.29595170 |
| 160 | PRKCQ | 0.29368196 |
| 161 | MAP3K6 | 0.29333721 |
| 162 | SIK2 | 0.27953471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35827171 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33249377 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30074424 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13926315 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96956133 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76484513 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65599766 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59751780 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56159096 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54149289 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42012007 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37965513 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30409211 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.27195533 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.11119674 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05943857 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04816768 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04628485 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97787203 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96190673 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90668029 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89241066 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86937084 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86905500 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79150876 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76671893 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75398637 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63720260 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60224798 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59344445 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57376065 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54033655 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.50684074 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50671324 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47792308 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.45651914 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.37618294 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36998396 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36502130 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36089186 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33050321 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32871930 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32492927 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.31668073 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30340913 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30337931 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.29559788 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26839213 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21009559 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16772035 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16391652 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16358681 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10892796 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 1.00638670 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99769672 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.96326057 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94827336 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94742839 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91810896 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90968951 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89102889 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86141949 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83677122 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82225172 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80834330 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80623631 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78483259 |
| 68 | * Folate biosynthesis_Homo sapiens_hsa00790 | 0.77887819 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75496006 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74858191 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74165558 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73652057 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69831859 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68667598 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68047933 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65659836 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64571728 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63426032 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63205239 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60528388 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.59089844 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58552875 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55738498 |
| 84 | * Sulfur relay system_Homo sapiens_hsa04122 | 0.55566469 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55535144 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.55177459 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54549640 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.53815711 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.51006496 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50390907 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.47415983 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42748897 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40944675 |
| 94 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40342532 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39937625 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.39831811 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39555894 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.39551573 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37328320 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36563491 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35688372 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31445522 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30026491 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.29933663 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22872751 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16521969 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15580009 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12642954 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12545700 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05972426 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00241065 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1172889 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1110941 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | -0.1104149 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1048496 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | -0.0948622 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0896242 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0869646 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0821613 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0748201 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0710745 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | -0.0666471 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0606234 |
| 124 | Malaria_Homo sapiens_hsa05144 | -0.0572250 |
| 125 | Lysosome_Homo sapiens_hsa04142 | -0.0529539 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0274051 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0234376 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0184498 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0161706 |
| 130 | Pertussis_Homo sapiens_hsa05133 | -0.0100443 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | -0.0072760 |

